Accounting Business Partner (ABP) is the central point of contact for the Shared Financial Service Center and other stakeholders within the organisation. • Ensuring high quality financial statements that can be used to drive business insights and results• Ensuring compliance with Merck’s reporting framework; Serving as the financial gatekeepers • Leveraging accounting knowledge and systems expertise to drive continuous process improvement• Collaborating with the value stream owners, bridging gaps across Merck Business Service for Merck’s local stakeholders and partners• Deep knowledge of IFRS and local GAAP together with tax awareness and audit experience• Pro-active, acting as a facilitator but also as a responsible decision maker and trouble-shooter mindset; Analytical skills enable precise communication; Networking and relationship building skills; Strong team player

Recognised for identifying and improving the accuracy and efficiency of accounting processes with a solid understanding of accounting principles. • Full general ledger responsibilities including managing the monthly and quarterly close process• Produced the monthly financial packet for business management• Lead continuous process improvement focusing on streamlining and automating processes• Strong organisation, planning, and project management skills; ability to drive and motivate team to achieve result• Recruited, performance managed, and developed the careers of staff and senior accountants• Supported internal and external audits

• Key member of general ledger team, responsible for many elements of monthly closings as well as quarter-end and year-end reporting and audit duties.• Analyze large actual to budget variances and work cross-functionally to review over 50 departments having an annual budget in excess of $350M.• Managed and reduced the cycle time for all equity transactions (FAS 123R) from 3 days to 1 day.• Reengineered the Statement of Cash Flows and other external statements, enabling HGS to accelerate its SEC filings by several days.• Accounted for investment portfolio at times over $800M, ensuring accurately recorded interest income and both realized and unrealized gains and losses; monitor securities for impairment.• Assumed interim manager-level responsibility for accounting for $130M+ clinical trials following departure of manager.• Reviewed capital requests for proper accounting treatment; maintain fixed asset subsidiary ledger with annual expenditures in excess of $6M.